Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515783 | PMC |
| http://dx.doi.org/10.4103/jpgm.JPGM_19_19 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development and refinement of patient care recommendations in brachytherapy for locally advanced cervical cancer using nominal group technique workshops.
Support Care Cancer
December 2024
College of Health, Science & Society, University of the West of England, Bristol, UK.
Purpose: Patient experiences of brachytherapy for locally advanced cervical cancer (LACC) are widely variable, with reports of difficult and traumatic experiences and aspects of care requiring improvement. The aim of this study was to develop patient care recommendations and consult with key stakeholders to review, refine and prioritise recommendations.
Methods: Phase 1: Patient care recommendations were developed from qualitative exploratory study data.
Prospects of nano-theranostic approaches against breast and cervical cancer.
Biochim Biophys Acta Rev Cancer
November 2024
Department of Clinical and Translational Research, Chittaranjan National Cancer Institute, 37 S.P. Mukherjee Road, Kolkata 700 026, India. Electronic address:
The bottleneck on therapeutics and diagnostics is removed by an alternate approach known as theranostics which combines both therapeutics and diagnostics within a single platform. Due to this "all in one" nature of theranostics, it is now extensively applied in the medicinal field mainly in cancer treatment over the conventional therapy. Recently, FDA approval of lutetium 177 (177Lu) DOTATATE and 177Lu-PSMA-based radionuclide theranostics are clinically used and very few theranostics specific to breast cancer are in clinical trials.
View Article and Find Full Text PDFPregnancy Following Spontaneous Healing of Uterine Rupture: A Case Report and Experience of Management.
Cureus
September 2024
General Center for Perinatal, Maternal and Neonatal Medicine, Niigata University Medical and Dental Hospital, Niigata, JPN.
Uterine rupture can heal naturally without the need for surgical intervention. However, reports on subsequent pregnancies are limited. A 27-year-old woman, gravida 2, para 1, visited our institution at seven weeks of gestation.
View Article and Find Full Text PDFUterine rupture following prostaglandins use in second trimester medical abortion: Fact or fiction? A systematic review.
Int J Gynaecol Obstet
October 2024
Unit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine (DIM), University of Bari "Aldo Moro", Bari, Italy.
Article Synopsis
- Prostaglandins (PGs) are vital in second trimester medical abortions but can lead to complications like maternal fever and uterine rupture (UR).
- This systematic review aimed to evaluate the safety of PGs, especially in women with a scarred uterus, using data from multiple medical databases published between 1990 and 2022.
- Although PGs are effective for medical abortion, they are associated with risks, necessitating the use of well-equipped and skilled obstetric teams for safer procedures.
Transcript analysis of uterus transplant cervical biopsies using the Banff Human Organ Transplant panel.
Am J Transplant
August 2024
Department of Clinical Pathology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden; Institute of Biomedicine, Department of Laboratory Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
Uterus transplantation is being more widely implemented in clinical practice. Monitoring of rejection is routinely done for cervical biopsies and is dependent on histopathological assessment, as rejections are clinically silent and nonhistological biomarkers are missing. Until this gap is filled, it is important to corroborate the histopathological diagnosis of rejection through independent methods such as gene expression analysis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!